Estetrol for Sexual Dysfunction

Palo Alto (17 mi)

Age: 18+

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Recruiting

Sponsor: Estetra

Prior Safety Data

Trial Summary

What is the purpose of this trial?This trial is testing estetrol, a hormone treatment, in postmenopausal women with sexual arousal disorder. The goal is to see if estetrol can help by balancing hormone levels. Participants will take estetrol for a few months and their progress will be monitored. Estetrol has been studied for its potential in hormone therapy, showing improvements in postmenopausal women.

Eligibility Criteria

This trial is for hysterectomized postmenopausal women aged 40 to 65 with Female Sexual Arousal Disorder. Candidates should not have significant abnormal gynecological findings, unresolved sexual trauma, recent major stress or relationship issues affecting sex life, high blood pressure, be unwilling to stop hormonal products during the study, or a history of cancer (except certain skin cancers).

Treatment Details

The trial tests if estetrol monohydrate (20 mg), a hormone treatment, can improve sexual arousal in postmenopausal women compared to a placebo. Participants will take the medication or placebo for 12 weeks and record their experiences daily while attending seven clinic visits.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: EstetrolExperimental Treatment1 Intervention

20 mg estetrol monohydrate

Group II: PlaceboPlacebo Group1 Intervention

Matching Placebo